| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Division of Nephrology and Hypertension, Department of Medicine, Oregon Health and Science University, and 3 Portland Veterans Affairs Medical Center, Portland, Oregon 97201-2940; and 2 Diabetes Center, Institute of Clinical and Experimental Medicine, Prague, Czech Republic
As an important modulator of renal function and morphology, the nitric oxide (NO) system has been extensively studied in the diabetic kidney. However, a number of studies in different experimental and clinical settings have produced often confusing data and contradictory findings. We have reviewed a wide spectrum of findings and issues that have amassed concerning the pathophysiology of the renal NO system in diabetes, pointed out the controversies, and attempted to find some explanation for these discrepancies. Severe diabetes with profound insulinopenia can be viewed as a state of generalized NO deficiency, including in the kidney. However, we have focused our hypotheses and conclusions on the events occurring during moderate glycemic control with some degree of treatment with exogenous insulin, representing more the clinically applicable state of diabetic nephropathy. Available evidence suggests that diabetes triggers mechanisms that in parallel enhance and suppress NO bioavailability in the kidney. We hypothesize that during the early phases of nephropathy, the balance between these two opposing forces is shifted toward NO. This plays a role in the development of characteristic hemodynamic changes and may contribute to consequent structural alterations in glomeruli. Both endothelial (eNOS) and neuronal NO synthase can contribute to altered NO production. These enzymes, particularly eNOS, can be activated by Ca2+-independent and alternative routes of activation that may be elusive in traditional methods of investigation. As the duration of exposure to the diabetic milieu increases, factors that suppress NO bioavailability gradually prevail. Increasing accumulations of advanced glycation end products may be one of the culprits in this process. In addition, this balance is continuously modified by actual metabolic control and the degree of insulinopenia.
reactive oxygen species; endothelial function; renal function; signal transduction; diabetic nephropathy
This article has been cited by other articles:
|
|
 |
|
  R. Shibata, S. Ueda, S.-i. Yamagishi, Y. Kaida, Y. Matsumoto, K. Fukami, A. Hayashida, H. Matsuoka, S. Kato, M. Kimoto, et al. Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy Nephrol. Dial. Transplant., April 1, 2009; 24(4): 1162 - 1169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Hohenstein Reply Nephrol. Dial. Transplant., September 1, 2008; 23(9): 3037 - 3038. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yuzawa, I. Niki, T. Kosugi, S. Maruyama, F. Yoshida, M. Takeda, Y. Tagawa, Y. Kaneko, T. Kimura, N. Kato, et al. Overexpression of Calmodulin in Pancreatic {beta} Cells Induces Diabetic Nephropathy J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1701 - 1711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Edgley, M. Tare, R. G. Evans, C. Skordilis, and H. C. Parkington In vivo regulation of endothelium-dependent vasodilation in the rat renal circulation and the effect of streptozotocin-induced diabetes Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2008; 295(3): R829 - R839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Hohenstein, C. P.M. Hugo, B. Hausknecht, K. P. Boehmer, R. H. Riess, and R. E. Schmieder Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1346 - 1354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Onozato, A. Tojo, J. Leiper, T. Fujita, F. Palm, and C. S. Wilcox Expression of NG,NG-Dimethylarginine Dimethylaminohydrolase and Protein Arginine N-Methyltransferase Isoforms in Diabetic Rat Kidney: Effects of Angiotensin II Receptor Blockers Diabetes, January 1, 2008; 57(1): 172 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Palm, M. L. Onozato, Z. Luo, and C. S. Wilcox Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3227 - H3245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Shi, D. Patschan, T. Epstein, M. S. Goligorsky, and J. Winaver Delayed recovery of renal regional blood flow in diabetic mice subjected to acute ischemic kidney injury Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1512 - F1517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Fitzgerald, B. K. Kemp-Harper, H. C. Parkington, G. A. Head, and R. G. Evans Endothelial dysfunction and arterial pressure regulation during early diabetes in mice: roles for nitric oxide and endothelium-derived hyperpolarizing factor Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R707 - R713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhang, H. Meng, Z.-H. Li, Z. Shu, X. Ma, and B.-X. Zhang Regulation of STIM1, store-operated Ca2+ influx, and nitric oxide generation by retinoic acid in rat mesangial cells Am J Physiol Renal Physiol, March 1, 2007; 292(3): F1054 - F1064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Just Mechanisms of renal blood flow autoregulation: dynamics and contributions Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R1 - R17. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Savino, P. Pelliccia, C. Schiavone, A. Primavera, S. Tumini, A. Mohn, and F. Chiarelli Serum and Urinary Nitrites and Nitrates and Doppler Sonography in Children With Diabetes Diabetes Care, December 1, 2006; 29(12): 2676 - 2681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Zhao, S. Wang, H. Cheng, M.-z. Zhang, T. Takahashi, A. B. Fogo, M. D. Breyer, and R. C. Harris Endothelial Nitric Oxide Synthase Deficiency Produces Accelerated Nephropathy in Diabetic Mice J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2664 - 2669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. Park, H. W. Kim, S. H. Ko, H. W. Chung, S. W. Lim, C. W. Yang, Y. S. Chang, A. Sugawara, Y. Guan, and M. D. Breyer Accelerated Diabetic Nephropathy in Mice Lacking the Peroxisome Proliferator-Activated Receptor {alpha}. Diabetes, April 1, 2006; 55(4): 885 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Z. Levine, M. Iacovitti, S. J. Robertson, and G. A. Mokhtar Modulation of single-nephron GFR in the db/db mouse model of type 2 diabetes mellitus Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R975 - R981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Just and W. J. Arendshorst Nitric oxide blunts myogenic autoregulation in rat renal but not skeletal muscle circulation via tubuloglomerular feedback J. Physiol., December 15, 2005; 569(3): 959 - 974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Palm, D. G. Buerk, P.-O. Carlsson, P. Hansell, and P. Liss Reduced Nitric Oxide Concentration in the Renal Cortex of Streptozotocin-Induced Diabetic Rats: Effects on Renal Oxygenation and Microcirculation Diabetes, November 1, 2005; 54(11): 3282 - 3287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-S. Huang, L.-Y. Chuang, J.-Y. Guh, C.-J. Chen, Y.-L. Yang, T.-A. Chiang, M.-Y. Hung, and T.-N. Liao Effect of Nitric Oxide-cGMP-Dependent Protein Kinase Activation on Advanced Glycation End-Product-Induced Proliferation in Renal Fibroblasts J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2318 - 2329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Lee, J. M. Sasser, J. L. Hobbs, A. Boriskie, D. M. Pollock, P. K. Carmines, and J. S. Pollock Posttranslational regulation of NO synthase activity in the renal medulla of diabetic rats Am J Physiol Renal Physiol, January 1, 2005; 288(1): F82 - F90. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Fan, J. Liao, M. Kobayashi, M. Yamashita, L. Gu, T. Gohda, Y. Suzuki, L. N. Wang, S. Horikoshi, and Y. Tomino Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice Nephrol. Dial. Transplant., December 1, 2004; 19(12): 3012 - 3020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chu and H. G. Bohlen High concentration of glucose inhibits glomerular endothelial eNOS through a PKC mechanism Am J Physiol Renal Physiol, September 1, 2004; 287(3): F384 - F392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Joles and H. A. Koomans Causes and Consequences of Increased Sympathetic Activity in Renal Disease Hypertension, April 1, 2004; 43(4): 699 - 706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Adler, H. Huang, M. S. Wolin, and P. M. Kaminski Oxidant Stress Leads to Impaired Regulation of Renal Cortical Oxygen Consumption by Nitric Oxide in the Aging Kidney J. Am. Soc. Nephrol., January 1, 2004; 15(1): 52 - 60. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
